Clinical Trial Details
| Trial ID: | L6877 |
| Source ID: | NCT00501397 |
| Associated Drug: | Ketoconazole |
| Title: | A Study of the Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy Volunteers |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: ketoconazole|DRUG: GSK189075 |
| Outcome Measures: | Primary: Plasma blood samples for GSK189075 at Day 1 Session 1, Days 5 & 6 Session 3, at Day 1 Session 1, Days 5 & 6 Session 3 urine collections for volume|urine collections for volume, glucose, & creatinine at Day 1 Session 1, Days 5 & 6 Session 3., at Day 1 Session 1, Days 5 & 6 Session 3. | Secondary: Adverse events: all visits, all visits|ECG,labs: Screening,Days -1 & 1 Session 1,Day 4 Session 2,Days 5-6 Session 3, Screening,Days -1 & 1 Session 1,Day 4 Session 2,Days 5-6 Session 3|Labs:followup, followup|Urine: Day 1 Session 1,Days 5-6 Session 3, Day 1 Session 1,Days 5-6 Session 3|Vitals: Screening,Days -1 & 1 Session 1,Days 1-4 Session 2,Days 5-6 Session 3,followup, Screening,Days -1 & 1 Session 1,Days 1-4 Session 2,Days 5-6 Session 3,followup |
| Sponsor/Collaborators: | Sponsor: GlaxoSmithKline |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 22 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2007-02 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2012-06-04 |
| Locations: | GSK Investigational Site, Columbus, Ohio, 43212, United States |
| URL: | https://clinicaltrials.gov/show/NCT00501397 |
